Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro

Arthritis and Rheumatism

Volumn 41, Issue 2, 1998, Pages 263-273

  Erlacher, Ludwig ^a,b   Ng, Chee Keng ^a   Ullrich, Robert ^b   Krieger, Sigurd ^b   Luyten, Frank P ^b,c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; MESSENGER RNA; MORPHOGEN; PROTEOGLYCAN; RECOMBINANT PROTEIN; SULFATE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CATTLE; CONTROLLED STUDY; EXPLANT; HUMAN; HUMAN TISSUE; LIMB DEVELOPMENT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; CADAVER; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HUMANS; PROSTAGLANDINS; TRYPSIN;

EID: 0031911668     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199802)41:2<263::AID-ART10>3.0.CO;2-5     Document Type: Article

References (29)

1. Chang SC, Hoang B, Thomas JT, Vukicevic S, Luyten FP, Ryba NJP, et al. Cartilage-derived morphogenetic proteins: new members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 1994;269:28227-34.
2. Luyten FP. Cartilage-derived morphogenetic proteins: key regulators in chondrocyte differentiation? Acta Orthop Scand 1995; Suppl 266:51-4.
3. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 1994;368: 639-43.
4. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP. A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 1996; 12:315-7.
5. Poole AR. Imbalances of anabolism and catabolism of cartilage matrix components in osteoarthritis. In: Kuettner KE, Goldberg VM, editors. Osteoarthritic disorders. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1995. p. 247-60.
6. Bartholomew JS, Handley CJ, Lowther DA. The effects of trypsin treatment on proteoglycan biosynthesis by bovine articular cartilage. Biochem J 1985;227:429-37.
7. Verbruggen G, Luyten FP, Veys EM. Repair function in organ cultured human cartilage: replacement of enzymatically removed proteoglycans during long-term organ culture. J Rheumatol 1985; 12:665-74.
8. Erlacher L, McCartney J, Piek E, ten Dijke P, Yanagishita M, Oppermann H, et al. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J Bone Miner Res. In press 1998.
9. Handley CJ, Ng CK, Curtis CJ. Introduction: short-and long-term explant culture of cartilage. In: Maroudas A, Kuettner K, editors. Methods in cartilage research. London: Academic Press, 1990. p. 105-8.
10. Luyten FP, Yu YM, Yanagishita M, Vukicevic S, Hammonds RG, Reddi AH. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem 1992;267:3691-5.
11. Schafer SJ, Luyten FP, Yanagishita M, Reddi AH. Proteoglycan metabolism is age related and modulated by isoforms of platelet-derived growth factor in bovine articular cartilage explant cultures. Arch Biochem Biophys 1993;302:431-8.
12. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
14. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-62.
15. Storm EE, Kingsley DM. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 1996;122:3969-79.
16. Luo G, Hofmann C, Bronckers ALJJ, Sohocki M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995;9:2808-20.
17. Lyons KM, Hogan BLM, Robertson EJ. Colocalization of BMP-7 and BMP-2 rnRNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech Dev 1995;50:71-8.
18. Vukicevic S, Luyten FP, Reddi AH. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci U S A 1989;86:8793-7.
19. Carrington JL, Chen P, Yanagishita M, Reddi AH. Osteogenin (bone morphogenetic protein-3) stimulates cartilage formation by chick limb bud cells in vitro. Dev Biol 1991; 146:406-15.
20. Chen P, Carrington JL, Hammonds RG, Reddi AH. Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res 1991;195:509-15.
21. Luyten FP, Chen P, Paralkar V, Reddi AH. Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp Cell Res 1994;210:224-9.
22. Flechtenmacher J, Huch K, Thonar EJ-MA, Mollenhauer JA, Davies SR, Schmid TM, et al. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 1996;39:1896-904.
23. Harrison ET Jr, Luyten FP, Reddi AH. Osteogenin promotes reexpression of cartilage phenotype by dedifferentiated articular chondrocytes in serum-free medium. Exp Cell Res 1991;192: 340-5.
24. Harrison ET Jr, Luyten FP, Reddi AH. Transforming growth factor-beta: its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogenin. In Vitro Cell Dev Biol 1992;28A:445-8.
25. Sailor LZ, Hewick RM, Morris ER. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J Orthop Res 1996;14:937-45.
26. Ten Dijke P, Miyazono K, Heldin CH. Signaling via heterooligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol 1996;8:139-45.
27. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-46.
28. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, et al. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 1995;130:217-26.
29. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, et al. Identification of type I and type II serine/ threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 1996;271:21345-52.